ATE350052T1 - Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma - Google Patents

Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma

Info

Publication number
ATE350052T1
ATE350052T1 AT96934628T AT96934628T ATE350052T1 AT E350052 T1 ATE350052 T1 AT E350052T1 AT 96934628 T AT96934628 T AT 96934628T AT 96934628 T AT96934628 T AT 96934628T AT E350052 T1 ATE350052 T1 AT E350052T1
Authority
AT
Austria
Prior art keywords
kaposi
sarcoma
treatment
human chorionic
hcg
Prior art date
Application number
AT96934628T
Other languages
English (en)
Inventor
Siegfried Schwarz
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT95RM000686A external-priority patent/ITRM950686A1/it
Priority claimed from IT96RM000309A external-priority patent/ITRM960309A1/it
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE350052T1 publication Critical patent/ATE350052T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96934628T 1995-10-16 1996-10-11 Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma ATE350052T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95RM000686A ITRM950686A1 (it) 1995-10-16 1995-10-16 Hcg nel sarcoma di kaposi
IT96RM000309A ITRM960309A1 (it) 1996-05-07 1996-05-07 Hcg nel sarcoma di kaposi

Publications (1)

Publication Number Publication Date
ATE350052T1 true ATE350052T1 (de) 2007-01-15

Family

ID=26332089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934628T ATE350052T1 (de) 1995-10-16 1996-10-11 Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma

Country Status (10)

Country Link
US (1) US6251402B1 (de)
EP (1) EP0865295B1 (de)
AT (1) ATE350052T1 (de)
AU (1) AU723646B2 (de)
CA (1) CA2243948C (de)
DE (1) DE69636814T2 (de)
DK (1) DK0865295T3 (de)
ES (1) ES2277348T3 (de)
PT (1) PT865295E (de)
WO (1) WO1997014428A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6319504B1 (en) * 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
IT1284876B1 (it) * 1996-08-07 1998-05-22 Applied Research Systems Hcg come inibitore della collagenasi
WO1999006438A2 (en) * 1997-08-01 1999-02-11 Universite De Montreal Compounds with anti-ks and anti-hiv activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9010058D0 (en) * 1990-05-04 1990-06-27 Health Lab Service Board Method and composition for the treatment of cancer
US5677275A (en) * 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin

Also Published As

Publication number Publication date
WO1997014428A1 (en) 1997-04-24
DE69636814D1 (de) 2007-02-15
CA2243948C (en) 2008-07-08
US6251402B1 (en) 2001-06-26
PT865295E (pt) 2007-02-28
CA2243948A1 (en) 1997-04-24
EP0865295B1 (de) 2007-01-03
DE69636814T2 (de) 2007-10-04
EP0865295A1 (de) 1998-09-23
ES2277348T3 (es) 2007-07-01
AU723646B2 (en) 2000-08-31
AU7289996A (en) 1997-05-07
DK0865295T3 (da) 2007-03-19

Similar Documents

Publication Publication Date Title
DE69008010D1 (de) Sauerstoffdelignifizierung und enzymatische Behandlung.
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE68909219D1 (de) Behandlung von obesitas.
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE68920775D1 (de) Behandlung von faserigen Materialien.
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
DE3280344D1 (de) Verwendung von retinoiden und minoxidil (2,4-diamino-6-piperidino-pyrimidine-3-oxid) zur verbesserung des wachstums von menschlichem kopfhaar und zur behandlung bestimmter typen von alopecia.
DE3785602D1 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
ATE78399T1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
DE68907423D1 (de) Behandlung der akne.
DE3888994D1 (de) Behandlung von androgener Alopecia mit 17-beta-n-mono-substituierten-carbamoyl-4-aza-5-alpha-androst-1-en-3-onen.
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69007486D1 (de) Verwendung von calciumantagonisten für die behandlung von narben.
ATE350052T1 (de) Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma
ATE179594T1 (de) Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
ATE100826T1 (de) Behandlung von celluloseblaettern.
NO892505L (no) Behandling av vandige dispersjoner.
DE69619051D1 (de) Behandlung von Füllstoffen mit Oxasilacycloalkanen
DE69132782D1 (de) Verwendung von angiotensin-ii-antagonisten in der behandlung der linken ventrikulären hypertrophie
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE3751510D1 (de) Düse zur Behandlung von Fäden.
NO901154L (no) Behandling av snorer, traader og fibre.
DE68900867D1 (de) 1,5-benzothiazepinderivate, ihre herstellung und ihre verwendung in der behandlung von kardiovasculaeren stoerungen.
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
ATE303158T1 (de) Verwendung von beta-interferon zur behandlung der restenose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0865295

Country of ref document: EP

REN Ceased due to non-payment of the annual fee